Vice President, US Obesity Medical Lead

• United States - Pennsylvania - Collegeville
• United States - New York - New York City
• United States - Massachusetts - Cambridge

We’re in relentless pursuit of breakthroughs that change patients’ lives. We innovate every day to make the world a healthier place.

To fully realize Pfizer’s purpose – Breakthroughs that change patients’ lives – we have established a clear set of expectations regarding “what” we need to achieve for patients and “how” we will go about achieving those goals.

Pfizer offers competitive compensation and benefits programs designed to meet the diverse needs of our colleagues.

The Vice President, US Medical Affairs Obesity Lead, is an integral member of the US Medical Leadership Team and reports to the Head of US Medical Affairs. The incumbent will lead a team and develop the vision and strategic direction to yield the highest level of medical impact for the US Obesity franchise in US Medical Affairs. The position has broad impact throughout the organization and requires obesity experience with an understanding of pharmaceutical business operations, products, strategic thinking skills, leadership ability, and strong knowledge of the stakeholder community and market dynamics.

With exceptional obesity portfolio knowledge this will contribute to the global obesity portfolio strategy. The leader is expected to build and maintain strong opinion leader relationships engaging in external collaborations to gain insight and to inform clinical development and life cycle plans.

The Vice President, US Medical Affairs Obesity Lead, will work with cross functional partners to leverage operational excellence for the US to ensure timely delivery of major clinical trials, IIRs, RWE and core data dissemination activities. Accountable to build the US medical budget and to execute with excellence and highest levels of integrity and compliance. The US Obesity Medical Lead will also facilitate and manage the team’s appropriate internal information sharing and coordination (e.g., with relevant U.S. commercial teams) to ensure that they are conducted in compliance with both Pfizer and external policies, guidelines, and regulations.

The Lead brings their leadership skills, technical expertise, and an in-depth understanding of medicine development to bear on all activities while putting the patient first within the spectrum of the Pfizer Core Values and Behaviors.

The Obesity Medical lead is responsible for leading the US Medical Obesity team comprised of Brand Medical teams across the Obesity portfolio. The incumbent will partner closely with the Internal Medicine (IM) category lead, Field Medical organizations, Global Medical, other Regional Heads, publications, Medical Excellence, Outcomes & Evidence, Clinical Sciences, PRD and the Commercial lead:

• To ensure a world class team with exceptional understanding of the US, one of the most important global markets
• To lead the US medical strategy and ensure US market medical needs are appropriately represented from data generation (in partnership with PRD, as appropriate) to evidence dissemination and education of key stakeholders across the pipeline, in-line and late-stage development portfolio
• Maintain exceptional peer and KOL relationships, and a superb understanding of the obesity US health care ecosystem and the access environment
• Maintains strong working relationships and communications with Pfizer commercial lines in the region and headquarters
• Serves as a member of the US Primary Care Leadership Team
• Maintains strong working relationships with necessary platform functions such as Legal, Compliance and People Experience.

Duties and Responsibilities may be delegated as appropriate, though the US Obesity Medical Lead retains accountability. These include but are not limited to:

• Engage on peer basis with medical directors of independent networks and other healthcare providing entities to develop mutually beneficial solutions enhancing patient care
• Chairs or leads the US Medical Affairs Team, as appropriate, which is the Medical governance body for the portfolio/assets
• Represents US medical affairs at the relevant asset team…